Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
We present the rare case of a fatal anaphylactic reaction to gadobutrol, a magnetic resonance imaging contrast agent, in a 42-year-old man. The patient underwent elective magnetic resonance imaging for diagnostic clarification of a suspicious finding in the abdomen. The patient had undergone contras...
Main Authors: | Sabine Franckenberg, MD, Florian Berger, MD, Sarah Schaerli, MD, Garyfalia Ampanozi, MD, Michael Thali, Prof., MD, Executive MBA HSG |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-02-01
|
Series: | Radiology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1930043317303667 |
Similar Items
-
Non-Cardiogenic Pulmonary Oedema Following the Use of Gadolinium-Based Contrast Medium: A Case Report
by: Nguyen Chilan, et al.
Published: (2020-08-01) -
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
by: Alessandra Splendiani, et al.
Published: (2019-09-01) -
Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
by: Caterina Beatrice Monti, et al.
Published: (2020-04-01) -
Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
by: V. O. Panov, et al.
Published: (2016-09-01) -
High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
by: Tommaso D’Angelo, et al.
Published: (2017-11-01)